•  

     

    Do you want to know how reliable your data are?

    PAASP is a global leader in the assessment and accreditation of nonclinical research practice in the field of life sciences. We provide services to facilitate the generation of robust and reliable data and enable improved and accelerated decision-making. Our mission is to increase the probability that basic nonclinical discoveries will translate into safe and effective clinical treatments.

    Click here to complete a brief data reliability survey

GET STARTED HERE

PAASP Services

Your partner in data quality and good research practice.

MORE

PAASP Network

Meet the scientific experts and professionals that make up our global team.

MEET

PAASP Resources

From our collection of resources, find the exact information you need.

MORE

PAASPort®

A tool to judge risk of bias in biomedical research

Identify potential sources of bias early and improve decision-making.

 

MORE

START YOUR JOURNEY TO ACCREDITATION

by getting detailed information about PAASPort®

Risks in early-stage biotech investment

As the recent cases illustrate, apparent or actual issues with data integrity and research rigor can damage not only reputation of individual scientists but also affect the value of companies, whether privately held or publicly traded.

PAASP introduces a new service for the investment community engaged in early-stage biotech:

PAASPort®-based assessment of investment opportunities for data integrity and research rigor risks.

MORE

OUR ACHIEVEMENTS

Initiatives that the PAASP Network
leads and participates in.

MORE

PAASP NETWORK PARTNERS ARE SUPPORTED BY
IMI Logo2014-VertPos 300px wide

Funder of EQIPD from the Innovative Medicines Initiative 2 Joint Undertaking.

Conferrer of the NIDA Challenge Award and SBIR Grant for PAASPort®.

BMBF_english_no margin

Sponsor of the projects GOT-ITQ-COFA, and DECIDE.

cvb-logo-jpg

United States sponsor of the Global Preclinical Data Forum and sponsor of the Negative Data Prize and PEERS project.

PARTNER ORGANIZATIONS

A taste of our most recent headlines.

How much power should my next study have: One size fits all?
March 14, 2022

There is a slow but steady increase in the number of publications where authors report on sample size justification.  In most…

Read More
Pre-study odds
March 14, 2022

One of the key themes in the 2005 seminal paper by John Ioannidis “Why most published research findings are false” is…

Read More
Additional reads in March 2022
March 14, 2022

The new normal? Redaction bias in biomedical science Why Discovering ‘Nothing’ in Science Can Be So Incredibly Important New Frontiers research…

Read More
Background

Be in the know!

Stay up-to-date with our newsletter.

Start your journey to accreditation

by getting detailed information about PAASPort®